MedPath

Early Versus Routine Abdominal Drain Removal After Live Liver DonorHepatectomy

Phase 2/3
Recruiting
Conditions
Live Liver Donors undergoing surgery
Medical and Surgical,
Registration Number
CTRI/2021/01/030702
Lead Sponsor
ILBS
Brief Summary

Prophylacticabdominal drainage after donor right hepatectomy for LDLT has been a common oreven mandatory practice in most transplant centres. This serves to monitor theoccurrence of postoperative intra abdominal bleeding and is used for thedetection and drainage of any bile leakage. However drain placement is notwithout any disadvantages like infective complications, increased pain, andprolonged hospital stay and bowel injury. In a study on non transplant liverresections by mitsuka et al, they validated 3x3 rule and concluded that therule is clinically feasible andallows for the early removal of the drain tube with minimum infection riskafter liver resection. There is no study done on live donor liver resection, interms of drain removal. We are doing a randomized control trial tocompare the safety of early drain removal versus standard drain removal afterdonor hepatectomy in terms of donor outcomes. We will analyse the data and elucidatethe safety of early drain removal using 3x3 rule with routine drain removal.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
60
Inclusion Criteria

live donor undergoing donor hepatectomy.

Exclusion Criteria

left lateral hepatectomy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
safety of early drain removal3 months
complications compared between both group using CCI.3 months
Secondary Outcome Measures
NameTimeMethod
bile leak3 months
readmission and reintervention rate30 days
bowel injury3 months
post operative pain score30 days
post op hospital stay15 days

Trial Locations

Locations (1)

institute of liver and biliary sciences

🇮🇳

Delhi, DELHI, India

institute of liver and biliary sciences
🇮🇳Delhi, DELHI, India
Parthiban
Principal investigator
7010752115
parthid2005@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.